L. Leopold
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 5
- Cancer-related Molecular Pathways 2
- Cancer Immunotherapy and Biomarkers 2
-
- Prostate Cancer Treatment and Research 6
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Yossi Shavit (1 shared paper)Jon Holmlund (5 shared papers)Guru Sonpavde (3 shared papers)Brian Wood (4 shared papers)Matthew Brookes (3 shared papers)J. R. Caton (2 shared papers)Petr Karlov (2 shared papers)Matt D. Galsky (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)Annals of Oncology (4 papers)European Journal of Cancer (2 papers)Blood (1 paper)European Sociological Review (1 paper)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
L. Leopold
26 papers receiving 437 citations
Peers
Comparison fields: 5 of 68
- Biological Psychiatry 26
- Oncology 169
- Pulmonary and Respiratory Medicine 131
- Genetics 29
- Cancer Research 35
Countries citing papers authored by L. Leopold
This map shows the geographic impact of L. Leopold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Leopold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Leopold more than expected).
Fields of papers citing papers by L. Leopold
This network shows the impact of papers produced by L. Leopold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Leopold. The network helps show where L. Leopold may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Leopold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 120 | |
| 2 | 2016 | 47 | |
| 3 | 2005 | 43 | |
| 4 | 2005 | 43 | |
| 5 | 2011 | 33 | |
| 6 | 2015 | 28 | |
| 7 | 2005 | 25 | |
| 8 | 2008 | 17 | |
| 9 | Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia | 2001 | 14 |
| 10 | 2006 | 11 | |
| 11 | 2009 | 11 | |
| 12 | 2009 | 10 | |
| 13 | 2006 | 9 | |
| 14 | 2009 | 8 | |
| 15 | 2009 | 7 | |
| 16 | Interim analysis of a phase II study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin to patients < 60 years old with untreated acute myeloid leukemia. | 2002 | 5 |
| 17 | 2009 | 4 | |
| 18 | 2009 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2008 | 2 |
About L. Leopold
L. Leopold is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 27 papers that have together received 448 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Prostate Cancer Treatment and Research (6 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biological Psychiatry (26 citations), Oncology (169 citations), Pulmonary and Respiratory Medicine (131 citations), Genetics (29 citations) and Cancer Research (35 citations). L. Leopold has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Yossi Shavit, Jon Holmlund, Guru Sonpavde, Brian Wood, Matthew Brookes, J. R. Caton, Petr Karlov, Matt D. Galsky, William L. Berry and Mark T. Fleming. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Blood and European Sociological Review.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.